These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8289972)

  • 1. Selective cervical cytology screening: discriminant analysis approach.
    Juneja A; Murthy NS; Sharma S; Shukla DK; Roy M; Das DK
    Neoplasma; 1993; 40(6):401-4. PubMed ID: 8289972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of longterm hospital based cytological screening in asymptomatic women.
    Misra JS; Singh U
    Diagn Cytopathol; 2006 Mar; 34(3):184-7. PubMed ID: 16470854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstaging of cervical cancer.
    Ananth R
    J Indian Med Assoc; 2000 Feb; 98(2):41-4. PubMed ID: 11016148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited education as a risk factor in cervical cancer.
    Corral F; Cueva P; Yépez J; Montes E
    Bull Pan Am Health Organ; 1996 Dec; 30(4):322-9. PubMed ID: 9041743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS; Gupta HP; Das V
    Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organization of screening programs in developing countries with reference to screening for cancer of the uterine cervix in India.
    Luthra UK; Rengachari R
    IARC Sci Publ; 1986; (76):273-88. PubMed ID: 3570411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cancer of uterine cervix and approaches adopted in India.
    Murthy NS; Mathew A
    Indian J Cancer; 1999; 36(2-4):154-62. PubMed ID: 10921220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening.
    Juneja A; Murthy NS; Tuteja RK; Sardana S; Das DK
    Neoplasma; 1997; 44(4):272-4. PubMed ID: 9473783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small family norm and uterine cervical cancer.
    Sehgal A; Murthy NS; Satyanarayana L; Singh V; Luthra UK
    Acta Obstet Gynecol Scand; 1989; 68(6):527-8. PubMed ID: 2520808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer in India--strategy for control.
    Prabhakar AK
    Indian J Cancer; 1992 Sep; 29(3):104-13. PubMed ID: 1292993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cytology screening in Calcutta and adjoining areas with special reference to carcinoma of the uterine cervix.
    Roy A; Dutta K; Majumdar J; Basu S; De S; De N; Chowdhury JR
    Indian J Public Health; 1990; 34(2):98-106. PubMed ID: 2102897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
    Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
    Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland.
    Viikki M; Pukkala E; Hakama M
    Acta Obstet Gynecol Scand; 2000 Jul; 79(7):576-9. PubMed ID: 10929958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of cancer of the cervix: global and national perspective.
    Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
    J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.